Population pharmacokinetc/pharmacodynamic modeling of paclitaxel and carboplatin in ovarian cancer

Clinical Cancer Research

Volumn 14, Issue 8, 2008, Pages 2517-

  Egorin, Merrill J ^a  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; PACLITAXEL;

AREA UNDER THE CURVE; CANCER CHEMOTHERAPY; DRUG CLEARANCE; DRUG MECHANISM; HUMAN; LETTER; OVARY CANCER; PRIORITY JOURNAL; THROMBOCYTOPENIA;

ANTINEOPLASTIC AGENTS; CARBOPLATIN; FEMALE; HUMANS; OVARIAN NEOPLASMS; PACLITAXEL;

EID: 42249092648     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-07-5049     Document Type: Letter

References (1)

1. Joerger M, Huitema ADR, Richel DJ, et al. Population pharmacokinetics and pharmacodynamics of paclitaxel and carboplatin in ovarian cancer patients: a study by the European organization for research and treatment of cancer-pharmacology and molecular mechanisms group and new drug development group. Clin Cancer Res 2007;13:6410-8.